Human recombinant interferon alpha-2C enhances the expression of class II HLA antigens on hairy cells

Luca Baldini(University of Milan), EE Polli(University of Milan), L Nobili(Istituto di Sessuologia Clinica), Antonino Neri(University of Milan), G Lambertenghi- Deliliers(Istituto di Sessuologia Clinica), Maiolo At(University of Milan), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), N Polli(Istituto di Sessuologia Clinica)

Blood

February 1, 1986

10.1182/blood.v67.2.458.458

Cited by 40

Related Papers

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

|Leukemia|2009|877

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

|The Lancet|2018|733

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

|Blood|2003|490

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

|Blood|2009|433

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

|Journal of Clinical Oncology|2016|394